Related by context. Frequent words. (Click for all words.) 66 unique PER.C6 ® 66 ® bortezomib 66 proprietary Mimetic Ligand 65 ALN TTR# 65 products Oncaspar 65 GRNVAC1 65 TRAIL receptor antibodies 65 Currently RegeneRx 65 R sorafenib tablets 65 based pretargeting methods 65 Onalta 65 BiTE R 65 Romidepsin 64 PSMA ADC 64 Nanobody 64 PEGylation technology 64 TLR9 agonist 64 Prodarsan ® 64 Daclizumab 64 Dapagliflozin 64 Initiates Phase II 64 AEG# 64 CORT # 63 peripherally acting 63 REGN# 63 anticancer compounds 63 Panzem R 63 JAK inhibitor 63 optical biosensors 63 Inovio clinical 63 novel antibody therapeutics 63 liposomal formulation 63 Panzem R NCD 63 refractory chronic lymphocytic 62 preclinical efficacy 62 Tesetaxel 62 Meets Primary Endpoint 62 TLR9 agonists 62 Thiarabine 62 CEQ# 62 KNS # 62 Taiho Pharmaceutical 62 MKC# 62 immuno inflammatory diseases 62 Locteron ® 62 inflammatory autoimmune diseases 62 rheumatoid arthritis psoriatic arthritis 62 commercialize phytocannabinoid based 62 Copegus R 62 StromaCel Inc. 62 Tibotec Pharmaceuticals Ltd. 62 fluoroquinolone class 62 interferon gamma 1b 62 TELINTRA 62 Pazopanib 62 PEGylated 61 CTLA4 Ig 61 novel anti infective 61 humanized antibodies 61 MVA BN R 61 Amgen discovers develops 61 Syncria 61 therapeutic monoclonal antibodies 61 huC# DM4 61 Commences Phase 61 DNA RNA Medicines 61 includes investigational compounds 61 Receives Orphan Drug Designation 61 elotuzumab 61 recombinant vaccines 61 non personalized allogeneic 61 boron chemistry 61 Completes Enrollment 61 forodesine 61 rilonacept 61 Sapacitabine 61 epothilones 61 topical anti infective 61 Lipid Polymer Micelle LPM 61 Racivir 61 PLK1 SNALP 61 KRN# 61 Factor VIIa 61 Study Evaluating 61 Phase Ib II 61 PARI Pharma 61 Argatroban 61 Amrubicin 61 Rebif ® 61 Amgen discovers develops manufactures 61 Diabetic Neuropathy 61 investigational compounds 61 Nexavar ® 61 L Annamycin 61 Carfilzomib 61 Adagen 60 proteasome inhibitor 60 Presents Positive 60 Vytorin combines 60 Testim R 60 Biolex Therapeutics